Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ 内部交易: 2018-01-18,Exec. VP International Ops,King Gary A. ,卖出,3120普通股, $38.12
$万基遗传(MYGN)$ 内部交易: 2018-01-18,Exec. VP International Ops,King Gary A. ,期权,3120普通股, $14.88
$万基遗传(MYGN)$ 内部交易: 2018-01-18,E.V.P., General Counsel,MARSH RICHARD M ,卖出,40000普通股, $38.25
$万基遗传(MYGN)$ 内部交易: 2018-01-18,E.V.P., General Counsel,MARSH RICHARD M ,期权,40000普通股, $30.12
$万基遗传(MYGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-19 AccNo: 0000215457-18-001197 Size: 13 KB 网页链接
$万基遗传(MYGN)$ 内部交易: 2018-01-12,E.V.P., General Counsel,MARSH RICHARD M ,卖出,13759普通股, $36.25
$万基遗传(MYGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-10 AccNo: 0000932471-18-000032 Size: 46 KB 网页链接
$万基遗传(MYGN)$ 内部交易: 2017-12-14,Director,GILBERT WALTER PHD ,卖出,7500普通股, $33.19
$万基遗传(MYGN)$ 内部交易: 2017-12-11,Director,DREISMANN HEINRICH ,卖出,6000普通股, $33.50
$万基遗传(MYGN)$ 8-K - Current report Filed: 2017-12-01 AccNo: 0001564590-17-024444 Size: 299 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of...